Retrieve available abstracts of 26 articles: HTML format
Single Articles
April 2025
SINGAL AK, Piano S Tapered Corticosteroids in Severe Alcohol-Associated Hepatitis: A Strategy to
Maximize Benefit and Minimize Harm.
Am J Gastroenterol. 2025 Apr 28. doi: 10.14309/ajg.0000000000003464. PubMed
MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al Rural-urban disparities in hepatocellular carcinoma deaths are driven by
hepatitis C-related HCC.
Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487. PubMedAbstract available
March 2025
KULKARNI AV, Kumar K, Giri S, Arab JP, et al Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated
Hepatitis: A Randomized Trial (STASH Trial).
Am J Gastroenterol. 2025 Mar 13. doi: 10.14309/ajg.0000000000003416. PubMedAbstract available
December 2024
CHUNG SW, Kim YJ, Lim J, Choi J, et al Risk of extrahepatic malignancies in patients with autoimmune hepatitis: a
nationwide cohort study.
Am J Gastroenterol. 2024 Dec 24. doi: 10.14309/ajg.0000000000003261. PubMedAbstract available
WU Y, Zhang Z Comments on Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal:
Results From a Large, Global, Multiethnic Cohort of Patients With Chronic
Hepatitis B (RETRACTB Study).
Am J Gastroenterol. 2024 Dec 16. doi: 10.14309/ajg.0000000000003206. PubMed
TERRAULT NA, Vargas HE Antivirals in Preventing Perinatal Transmission of Hepatitis B: Start and Stop
Times are Shifting.
Am J Gastroenterol. 2024 Dec 10. doi: 10.14309/ajg.0000000000003177. PubMed
November 2024
LV J Challenges in Expanding Structured Chronic Hepatitis B Surveillance Programs.
Am J Gastroenterol. 2024 Nov 20. doi: 10.14309/ajg.0000000000003187. PubMed
October 2024
COLAPIETRO F, Piovani D, Pugliese N, Aghemo A, et al Is ChatGPT a reliable tool in Autoimmune Hepatitis?
Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003179. PubMedAbstract available
WENTWORTH BJ, McGrath M, Khanna S, Lammert C, et al Autoimmune Hepatitis and the Pathways and Targets for Therapies.
Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003163. PubMed
ZENG QL, Zhou YH, Dong XP, Zhang JY, et al Expected Eight-Week Prenatal Versus Twelve-Week Perinatal Tenofovir Alafenamide
Prophylaxis to Prevent Mother-To-Child Transmission of Hepatitis B Virus: A
Multicenter, Prospective, Open-label, Randomized Controlled Trial.
Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003122. PubMedAbstract available
CHAI KP, Saxena V, Seo S, Horton BH, et al A chronic hepatitis B identification and surveillance program improves care in an
integrated health plan.
Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003116. PubMedAbstract available
August 2024
MISHRA AK, Shasthry SM, Vijayaraghavan R, Kumar G, et al Granulocyte colony stimulating factor improves Prednisolone responsiveness and
90-day survival in steroid eligible severe Alcohol associated Hepatitis: The
GPreAH Study a randomized trial.
Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003038. PubMedAbstract available
July 2024
DUKEWICH M, Dodge JL, Lucey MR, Rice JP, et al The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early
Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center
ACCELERATE Study.
Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002956. PubMedAbstract available
LEE WM, Barnard C, Rule JA, Orandi BJ, et al Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in
Patients with Viral Hepatitis-Associated Acute Liver Failure.
Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002941. PubMedAbstract available
June 2024
HUANG SC, Su TH, Tseng TC, Liao SH, et al Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its
complication risks in chronic hepatitis B.
Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915. PubMedAbstract available
May 2024
RAO S, Qazi S, Lee D, Molliner C, et al Multiple Barriers Impede Screening for Hepatitis Delta: An Internet-Based Survey
of Healthcare Providers.
Am J Gastroenterol. 2024 May 9. doi: 10.14309/ajg.0000000000002810. PubMedAbstract available
KARIME C, Black CN, Cortes P, Kwon JY, et al Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease
without Immunity Following Two-Dose Heplisav-B Vaccination.
Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002863. PubMedAbstract available
April 2024
HUME SJ, Holmes JA, Thompson AJ Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low
HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of
Hepatic Decompensation?
Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766. PubMed
WANG Y, Huang Y, Antwi SO, Taner CB, et al Racial Disparities in Liver Disease Mortality Trends Among Black and White
Populations in the United States, 1999-2020: An Analysis of CDC WONDER Database.
Am J Gastroenterol. 2024;119:682-689. PubMedAbstract available
March 2024
HIRODE G, Hansen BE, Chen CH, Su TH, et al Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from
a large, global, multi-ethnic cohort of patients with chronic hepatitis B
(RETRACT-B study).
Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002759. PubMedAbstract available
HIRODE G, Hansen BE, Chen CH, Su TH, et al Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog
Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients
With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718. PubMed
February 2024
BUI H, Kumar NG, Singal AG, Boparai J, et al Implementation of a hepatocellular carcinoma surveillance program in a
community-based integrated health system in patients with hepatitis C cirrhosis.
Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704. PubMedAbstract available
HSU CE, Liaw YF Hepatitis B Surface Antigen Kinetics After Tenofovir Withdrawal in Chronic
Hepatitis B.
Am J Gastroenterol. 2024;119:389-390. PubMed
January 2024
JOPHLIN LL, Singal AK, Bataller R, Wong RJ, et al ACG Clinical Guideline: Alcohol-Associated Liver Disease.
Am J Gastroenterol. 2024;119:30-54. PubMedAbstract available
December 2023
HU TH, Luh DL, Tsao YY, Lin TY, et al Utilizing the Diabetes Care System for A County-wide Hepatitis C Elimination: An
Integrated Community-based Shared Care Model in Taiwan.
Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002624. PubMedAbstract available
BARRITT AS 4TH, Barnhart H, Gu J, Dellinger A, et al When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of
Unlikely Cases From the Drug-Induced Liver Injury Network.
Am J Gastroenterol. 2023;118:2301-2304. PubMedAbstract available